Clinical Trials Browser

Adenocarcinoma, Adenoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Adenoma, Islet Cell, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Glandular and Epithelial, Neoplasms, Nerve Tissue, Pancreatic Diseases, Pancreatic Neoplasms, Neuroectodermal Tumors, Neuroendocrine Tumors

NCT00393796 2014-11-13

Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma

Phase 2 Terminated

54 enrolled 9 charts

Genitourinary

Urinary Bladder Neoplasms

NCT00910039 2014-09-29

Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases

Phase 2 Terminated

14 enrolled 12 charts

CNS

Brain Neoplasms, Neoplasm Metastasis

NCT00570908 2014-09-18

Brain Mets - Capecitabine Plus Sunitinib and WBRT

Phase 2 Terminated

12 enrolled 7 charts

BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT00387426 2014-05-28

Sunitinib in Treating Patients With Idiopathic Myelofibrosis

Phase 2 Terminated

14 enrolled 5 charts

LymphoidMyeloidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Leukemia, Hairy Cell, Leukemia, Mast-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT01215565 2014-03-13

Fibrolam

Phase 2 Terminated

4 enrolled

Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Adenocarcinoma, Carcinoma, Digestive System Neoplasms, Fibrosis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Pathologic Processes

NCT01216657 2013-06-04

Trial of Single Agent Sunitinib for Patients With Chemo-refractory Metastatic Melanoma

Phase 2 Terminated

7 enrolled

Dermatologic

Melanoma

NCT00609622 2012-10-11

Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer

Phase 2 Terminated

191 enrolled 10 charts

Gastrointestinal

Colorectal Neoplasms

NCT00495625 2012-03-27

Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC)

Phase 2 Terminated

33 enrolled 11 charts

Gastrointestinal

Liver Neoplasms

NCT00434356 2009-12-03

A Study of Sunitinib in Combination With Bevacizumab and Paclitaxel in Previously Untreated Patients With Metastatic Breast Cancer (SABRE-B)

Phase 2 Terminated

46 enrolled 8 charts

Breast

Breast Neoplasms

NCT00434226 2009-08-21

A Study of Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (SABRE-L)

Phase 2 Terminated

56 enrolled 6 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00491738 2009-04-10

A Study Evaluating the Efficacy and Safety of Sunitinib With or Without Bevacizumab in First-Line Patients With Metastatic Renal Cell Cancer (SABRE-R)

Phase 2 Terminated

16 enrolled 5 charts

Genitourinary

Carcinoma, Renal Cell

Clinical Trials

Sunitinib and Capecitabine for First Line Colon Cancer

Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow

Sunitinib in Sarcomas of the Central Nervous System

Targeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia

NIVOSWITCH

Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma

Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer

TAURUS

Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery

Sunitinib in Certain Subtypes of Soft Tissue Sarcomas

Efficacy of SU 011248 in Head And Neck Carcinoma

A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Sunitinib Malate in Treating Patients With Recurrent Transitional Cell Bladder Cancer

Personalized Targeted Inhibitors Treatment in Renal Cell Cancer

Sunitinib Malate in Treating Patients With Small Cell Lung Cancer

A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian Population

Sunitinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Who Have Tumor Cells in the Bone Marrow

TOKIO

SUNRISES

Trial of Adjuvant Sutent for Patients With High Risk Urothelial Carcinoma After Neoadjuvant Chemotherapy and Cystectomy

Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver Cancer

Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Phase II Study of Sunitinib Rechallenge in Patients With Metastatic Renal Cell Carcinoma

Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma

Sunitinib Malate in Refractory Germ Cell Tumors

Neoadjuvant Cisplatin, Gemcitabine, Sunitinib Malate + Radical Cystectomy for TCC

Multimodality Phase II Study in Prostate Cancer

A Study of Neoadjuvant Sutent for Patients With Renal Cell Carcinoma

A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma

Sunitinib to Treat Recurrent Brain Cancer

NET

Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma

Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases

Brain Mets - Capecitabine Plus Sunitinib and WBRT

Sunitinib in Treating Patients With Idiopathic Myelofibrosis

Fibrolam

Trial of Single Agent Sunitinib for Patients With Chemo-refractory Metastatic Melanoma

Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer

Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC)

A Study of Sunitinib in Combination With Bevacizumab and Paclitaxel in Previously Untreated Patients With Metastatic Breast Cancer (SABRE-B)

A Study of Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (SABRE-L)

A Study Evaluating the Efficacy and Safety of Sunitinib With or Without Bevacizumab in First-Line Patients With Metastatic Renal Cell Cancer (SABRE-R)